| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.9 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |